About
CytaCoat develops and commercializes a permanent, covalent, non-releasing antibacterial and anti-biofilm coating technology for medical devices to prevent biofilm formation and improve patient outcomes, particularly in urinary catheter and wound care applications.
Explore CytaCoat's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.